randomized controlled trial
DESCRIPTION
RANDOMIZED CONTROLLED TRIAL. DR. SANJAY P. ZODPEY, MD, PhD JULY 9-13, 2007 MGIMS-SEWAGRAM, IAPSM -EPIDEMIOLOGY COMMITTEE & MAHARASHTRA CHAPTER. RANDOMIZED CONTROLLED TRIAL. Objectives: To understand the design issues related to RCTs To know various steps involved in conduct of RCTs - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: RANDOMIZED CONTROLLED TRIAL](https://reader031.vdocuments.us/reader031/viewer/2022012316/56813493550346895d9b7ca5/html5/thumbnails/1.jpg)
1
RANDOMIZED CONTROLLED TRIAL
DR. SANJAY P. ZODPEY, MD, PhD
JULY 9-13, 2007
MGIMS-SEWAGRAM, IAPSM -EPIDEMIOLOGY COMMITTEE & MAHARASHTRA CHAPTER
![Page 2: RANDOMIZED CONTROLLED TRIAL](https://reader031.vdocuments.us/reader031/viewer/2022012316/56813493550346895d9b7ca5/html5/thumbnails/2.jpg)
2
RANDOMIZED CONTROLLED TRIAL
Objectives:
1. To understand the design issues related to RCTs
2. To know various steps involved in conduct of RCTs
3. To know various types of clinical trials
![Page 3: RANDOMIZED CONTROLLED TRIAL](https://reader031.vdocuments.us/reader031/viewer/2022012316/56813493550346895d9b7ca5/html5/thumbnails/3.jpg)
3
RANDOMIZED CONTROLLED TRIAL
-Earlier public health measures were introduced on the basis of assumed benefits without subjecting them to rigorous testing
- Last 30 to 40 years – Evolution of Randomized Controlled Trials
![Page 4: RANDOMIZED CONTROLLED TRIAL](https://reader031.vdocuments.us/reader031/viewer/2022012316/56813493550346895d9b7ca5/html5/thumbnails/4.jpg)
4
CLINICAL TRIALS• Prospective study comparing the effect and
value of one of more interventions against a control in human subjects with a given medical condition.
• Measures causality in terms of the effect of an intervention: If one alters the risk factor, does one alter the occurrence of the event/injury?
• "...the most definitive tool for evaluation of the applicability of clinical research.“
![Page 5: RANDOMIZED CONTROLLED TRIAL](https://reader031.vdocuments.us/reader031/viewer/2022012316/56813493550346895d9b7ca5/html5/thumbnails/5.jpg)
5
RANDOMIZED CONTROLLED TRIAL
• A true experiment, in which the researcher randomly assigns some patients to at least one maneuver (treatment) and other patients to a placebo, or usual treatment.
• Key features– the classic way to evaluate efficacy or effectiveness
of drugs (or exercise, diet, counseling)– patients are followed over time (prospective)
• Properly done, an RCT can be used to determine cause and effect.
![Page 6: RANDOMIZED CONTROLLED TRIAL](https://reader031.vdocuments.us/reader031/viewer/2022012316/56813493550346895d9b7ca5/html5/thumbnails/6.jpg)
6
The ideal clinical trial is one that is randomized and double-blind.
“RANDOMIZED, DOUBLE-BLIND, CONTROLLED TRIAL” is considered as research design par excellence and “GOLD STANDARD” amongst research designs with which results of other studies are often compared. Deviation from this standard has potential drawbacks
![Page 7: RANDOMIZED CONTROLLED TRIAL](https://reader031.vdocuments.us/reader031/viewer/2022012316/56813493550346895d9b7ca5/html5/thumbnails/7.jpg)
7
A clinical trial must employ one or more intervention techniques.
These may be :
1. Prophylactic
2. Diagnostic
3. Therapeutic agents
4. Devices
5. Regimens
6. Procedure
![Page 8: RANDOMIZED CONTROLLED TRIAL](https://reader031.vdocuments.us/reader031/viewer/2022012316/56813493550346895d9b7ca5/html5/thumbnails/8.jpg)
8
STEPS IN CONDUCT OF RCT:
1. The protocol
2. Selecting reference and experimental populations
3. Randomization
4. Intervention
5. Follow up
6. Assessment
![Page 9: RANDOMIZED CONTROLLED TRIAL](https://reader031.vdocuments.us/reader031/viewer/2022012316/56813493550346895d9b7ca5/html5/thumbnails/9.jpg)
9
CLINICAL TRIAL
Population - - - -
Of patients - - - -
With the - - - -
Condition - - - -
SAMPLE
-- ALLOCATION
INTERVENTION GROUPImproved
NotImproved
CONTROL GROUP
Improved
Not Improved
![Page 10: RANDOMIZED CONTROLLED TRIAL](https://reader031.vdocuments.us/reader031/viewer/2022012316/56813493550346895d9b7ca5/html5/thumbnails/10.jpg)
10
1. The Protocol- Aims and objectives, Research questions,
Selection criteria, Sample size, procedures up to the evaluation of outcome
- Prevents bias and reduces the sources of errors
- Preliminary test runs – feasibility or operational efficiency
![Page 11: RANDOMIZED CONTROLLED TRIAL](https://reader031.vdocuments.us/reader031/viewer/2022012316/56813493550346895d9b7ca5/html5/thumbnails/11.jpg)
11
2. Selecting Reference and Experimental Populations
a. Reference or target population - population to which the findings of the trial, if found successful, are expected to be applicable (eg. drugs, vaccines, etc.)
b. Experimental or study population - actual population that participates in the experimental study
![Page 12: RANDOMIZED CONTROLLED TRIAL](https://reader031.vdocuments.us/reader031/viewer/2022012316/56813493550346895d9b7ca5/html5/thumbnails/12.jpg)
12
Participants must fulfill the following criteria:
- Must give informed consent
- Should be representative of the population
- Should be qualified or eligible for the trial
![Page 13: RANDOMIZED CONTROLLED TRIAL](https://reader031.vdocuments.us/reader031/viewer/2022012316/56813493550346895d9b7ca5/html5/thumbnails/13.jpg)
13
SAMPLE SIZE
Clinical trials should have sufficient statistical power to detect differences between groups considered to be of clinical interest. Therefore, calculation of sample size with provision for adequate levels of significance and power is essential part of planning.
![Page 14: RANDOMIZED CONTROLLED TRIAL](https://reader031.vdocuments.us/reader031/viewer/2022012316/56813493550346895d9b7ca5/html5/thumbnails/14.jpg)
14
3. Randomization
- Heart of the control trial
- Procedure: Participants are allocated into study and control groups
- Eliminates bias and allows comparability
![Page 15: RANDOMIZED CONTROLLED TRIAL](https://reader031.vdocuments.us/reader031/viewer/2022012316/56813493550346895d9b7ca5/html5/thumbnails/15.jpg)
15
- Both groups should be alike with regards to certain variables that might affect the outcome of the experiment
- Best done by using table of random numbers
![Page 16: RANDOMIZED CONTROLLED TRIAL](https://reader031.vdocuments.us/reader031/viewer/2022012316/56813493550346895d9b7ca5/html5/thumbnails/16.jpg)
16
RANDOMIZATION
Randomization tends to produce study groups comparable with respect to known as well as unknown risk factors, removes investigator bias in the allocation of subjects and guarantees that statistical tests will have valid significance levels.
![Page 17: RANDOMIZED CONTROLLED TRIAL](https://reader031.vdocuments.us/reader031/viewer/2022012316/56813493550346895d9b7ca5/html5/thumbnails/17.jpg)
17
4. Manipulation / Intervention
- Deliberate application or withdrawal or reduction of a suspected causal factor
- It creates an independent variable
![Page 18: RANDOMIZED CONTROLLED TRIAL](https://reader031.vdocuments.us/reader031/viewer/2022012316/56813493550346895d9b7ca5/html5/thumbnails/18.jpg)
18
5. Follow Up
- Implies examination of the experimental and control group subjects at defined intervals of time, in a standard manner, with equal intensity, under the same given circumstances
- Attrition: Inevitable losses to follow up
![Page 19: RANDOMIZED CONTROLLED TRIAL](https://reader031.vdocuments.us/reader031/viewer/2022012316/56813493550346895d9b7ca5/html5/thumbnails/19.jpg)
19
6. Assessment
- Positive results
- Negative results
- Biases: Subject variation, Observer bias, Evaluation bias
- Can be corrected by blinding
![Page 20: RANDOMIZED CONTROLLED TRIAL](https://reader031.vdocuments.us/reader031/viewer/2022012316/56813493550346895d9b7ca5/html5/thumbnails/20.jpg)
20
BLINDING
•UNBLINDED, OPEN TRIAL
•SINGLE BLIND
•DOUBLE BLIND
•TRIPLE BLIND
![Page 21: RANDOMIZED CONTROLLED TRIAL](https://reader031.vdocuments.us/reader031/viewer/2022012316/56813493550346895d9b7ca5/html5/thumbnails/21.jpg)
21
Some Study Designs:
1. Concurrent Parallel Study Designs
2. Cross Over Type of Study Designs
![Page 22: RANDOMIZED CONTROLLED TRIAL](https://reader031.vdocuments.us/reader031/viewer/2022012316/56813493550346895d9b7ca5/html5/thumbnails/22.jpg)
22
INTERVENTION
SUBJECTS
CONTROL
RANDOM
ALLOCATION
PERIOD 2
CROSS OVER DESIGN
PERIOD 1
![Page 23: RANDOMIZED CONTROLLED TRIAL](https://reader031.vdocuments.us/reader031/viewer/2022012316/56813493550346895d9b7ca5/html5/thumbnails/23.jpg)
23
ETHICS
IMPORTANT ISSUE IN CLINICAL TRIALS
ETHICAL CLEARANCE
* INSTITUTIONAL REVIEW BOARDS
* ETHICAL COMMITTEES
* ICMR GUIDELINES
* FEDERAL/STATE GUIDELINES
“INFORMED CONSENT”
![Page 24: RANDOMIZED CONTROLLED TRIAL](https://reader031.vdocuments.us/reader031/viewer/2022012316/56813493550346895d9b7ca5/html5/thumbnails/24.jpg)
24
Types of Randomized Controlled Trials:
1. Clinical Trial
- Concerned with evaluating therapeutic agent, mainly drugs
eg. Evaluation of beta-blockers in reducing cardiovascular mortality
- Not all clinical trials are susceptible to being blinded
![Page 25: RANDOMIZED CONTROLLED TRIAL](https://reader031.vdocuments.us/reader031/viewer/2022012316/56813493550346895d9b7ca5/html5/thumbnails/25.jpg)
25
2. Preventive Trials:
- Trial of primary preventive measures eg. Vaccines
- Analysis of preventive trials must result in clear statement about benefits to community, risk involved and cost to health
![Page 26: RANDOMIZED CONTROLLED TRIAL](https://reader031.vdocuments.us/reader031/viewer/2022012316/56813493550346895d9b7ca5/html5/thumbnails/26.jpg)
26
3. Risk Factor Trials:
- Investigator intervenes to interrupt the usual sequence in the development of disease for those individuals who have risk factor for developing the disease
- Primary prevention of CHD using clofibrate to lower serum cholesterol
![Page 27: RANDOMIZED CONTROLLED TRIAL](https://reader031.vdocuments.us/reader031/viewer/2022012316/56813493550346895d9b7ca5/html5/thumbnails/27.jpg)
27
4. Cessation Experiment:
- An attempt is made to evaluate the termination of a habit which is considered to be causally related to disease
- Cigarette smoking and lung cancer
![Page 28: RANDOMIZED CONTROLLED TRIAL](https://reader031.vdocuments.us/reader031/viewer/2022012316/56813493550346895d9b7ca5/html5/thumbnails/28.jpg)
28
5. Trials of Etiological Agents:
- To confirm or refute an etiological hypothesis
6. Evaluation of Health Services:
- Domiciliary treatment of PTB was as effective as more costlier hospital or sanatorium treatment
![Page 29: RANDOMIZED CONTROLLED TRIAL](https://reader031.vdocuments.us/reader031/viewer/2022012316/56813493550346895d9b7ca5/html5/thumbnails/29.jpg)
29
MULTICENTER TRIALS
Reasons for Multi-center Trials :
1. To recruit necessary number of subjects within a reasonable time.
2. May assure a more representative sample of the study or target population
3. Enables investigators with similar interest and skills to work together on a common problem
![Page 30: RANDOMIZED CONTROLLED TRIAL](https://reader031.vdocuments.us/reader031/viewer/2022012316/56813493550346895d9b7ca5/html5/thumbnails/30.jpg)
30
PHASES OF TRIALS
Phase I Trials:
• Initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and / or patients
![Page 31: RANDOMIZED CONTROLLED TRIAL](https://reader031.vdocuments.us/reader031/viewer/2022012316/56813493550346895d9b7ca5/html5/thumbnails/31.jpg)
31
PHASES OF TRIALS
Phase II Trials:
• Controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in patients with disease or condition under study and to determine the common short-term side effects and risks
![Page 32: RANDOMIZED CONTROLLED TRIAL](https://reader031.vdocuments.us/reader031/viewer/2022012316/56813493550346895d9b7ca5/html5/thumbnails/32.jpg)
32
PHASES OF TRIALS
Phase III Trials:
• Expanded controlled and uncontrolled trials after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug
![Page 33: RANDOMIZED CONTROLLED TRIAL](https://reader031.vdocuments.us/reader031/viewer/2022012316/56813493550346895d9b7ca5/html5/thumbnails/33.jpg)
33
PHASES OF TRIALS
Phase IV Trials:
• Post-marketing studies to delineate additional information including the drug’s risks, benefits, and optimal use